NRX Pharmaceuticals, Inc. — Investor Relations & Filings
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics for central nervous system (CNS) disorders. The company focuses on addressing high unmet medical needs for patients with life-threatening conditions, particularly suicidal depression, suicidal bipolar depression, and post-traumatic stress disorder (PTSD). Its development pipeline is based on its N-methyl-D-aspartate (NMDA) receptor platform. The lead candidate, NRX-101, is an investigational oral medication for suicidal bipolar depression that has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration (FDA). Other key programs include NRX-100 for suicidal ideation and KETAFREE™, a preservative-free ketamine product.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 10-Q | 2026-05-15 | English | |
| 10-K - NRX Pharmaceuticals, Inc. (0001719406) (Filer) | 2026-03-23 | English | |
| NRx Builds Momentum From FDA Progress To Strategic Expansion | 2026-02-27 | English | |
| ARS - NRX PHARMACEUTICALS, INC. (0001719406) (Filer) | 2026-02-23 | English | |
| DEF 14A - NRX PHARMACEUTICALS, INC. (0001719406) (Filer) | 2026-02-23 | English | |
| 3 Filing | 2026-02-17 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 46362258 | FORM 10-Q | 2026-05-15 | English | ||
| 33016320 | 10-K - NRX Pharmaceuticals, Inc. (0001719406) (Filer) | 2026-03-23 | English | ||
| 32842675 | NRx Builds Momentum From FDA Progress To Strategic Expansion | 2026-02-27 | English | ||
| 32897212 | ARS - NRX PHARMACEUTICALS, INC. (0001719406) (Filer) | 2026-02-23 | English | ||
| 32897213 | DEF 14A - NRX PHARMACEUTICALS, INC. (0001719406) (Filer) | 2026-02-23 | English | ||
| 31455206 | 3 Filing | 2026-02-17 | English | ||
| 31455134 | 8-K Filing | 2026-02-17 | English | ||
| 31455132 | 4 Filing | 2026-02-17 | English | ||
| 31455059 | 8-K Filing | 2026-02-17 | English | ||
| 31455038 | 424B5 Filing | 2026-02-17 | English | ||
| 31455029 | 8-K Filing | 2026-02-02 | English | ||
| 13065785 | FORM 8-K | 2026-01-16 | English | ||
|
2025
3 filings
| |||||
| 13065786 | FORM 8-K | 2025-12-29 | English | ||
| 13065787 | Regulatory Filings 2025 | 2025-12-23 | English | ||
| 13065788 | FORM 424B3 | 2025-12-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-onc…
|
ATORX | SE | Manufacturing |
|
Allmed Medical Products Co., Ltd
Manufacturer of medical dressings, surgical kits, and dispo…
|
002950 | CN | Manufacturing |
|
Allogene Therapeutics, Inc.
Develops off-the-shelf allogeneic CAR T therapies for cance…
|
ALLO | US | Manufacturing |
|
Almirall S.A.
Global biopharmaceutical company specializing in medical de…
|
ALM | ES | Manufacturing |
|
ALNYLAM PHARMACEUTICALS, INC.
A biopharmaceutical company developing RNA interference (RN…
|
ALNY | US | Manufacturing |
|
Alpa Laboratories Limited
WHO-GMP certified manufacturer of human and veterinary phar…
|
ALPA | IN | Manufacturing |
|
Alpha Cognition Inc.
A biopharmaceutical company developing treatments for neuro…
|
ACOG | CA | Manufacturing |
|
Alphamab Oncology
Innovative biopharma specializing in differentiated anti-tu…
|
9966 | KY | Manufacturing |
|
Alpha Teknova, Inc.
Manufacturer of critical reagents for the life sciences ind…
|
TKNO | US | Manufacturing |
|
ALTERITY THERAPEUTICS LTD
A clinical-stage biotech developing novel treatments for ne…
|
ATHE | US | Manufacturing |
NRX Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34346/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34346 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34346 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34346 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34346}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NRX Pharmaceuticals, Inc. (id: 34346)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.